1-3 of 3
Srikanta Jana
Close
Sort by
Journal Articles

Superior Efficacy of CAR-T Cells Using Marrow-Infiltrating Lymphocytes (MILs TM ) As Compared to Peripheral Blood Lymphocytes (PBLs)

Eric R. Lutz, PhD, Srikanta Jana, PhD, Lakshmi Rudraraju, MS, Elizabeth DeOliveira, Jing Zhou, Sean Mackay, Ivan M. Borrello, MD, Kimberly Noonan, PhD MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 4437.
https://doi.org/10.1182/blood-2019-130629
Published: 2019
Journal Articles

Marrow-Infiltrating Lymphocytes (MILs) Provide a Robust Platform for CAR-T Cell Therapy

Eric R. Lutz, PhD, Valentina Hoyos, MD, Lakshmi Rudraraju, MS, Elizabeth DeOliveira, Srikanta Jana, PhD, Ido Weiss, PhD, Ivan M. Borrello, MD, Kimberly Noonan, PhD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 3337.
https://doi.org/10.1182/blood-2018-99-118580
Published: 2018
Journal Articles

Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5

Ryan D. Schulteis, Haiyan Chu, Xuezhi Dai, Yuhong Chen, Brandon Edwards, Dipica Haribhai, Calvin B. Williams, Subramaniam Malarkannan, Martin J. Hessner, Sanja Glisic-Milosavljevic, Srikanta Jana, Edward J. Kerschen, Soumitra Ghosh, Demin Wang, Anne E. Kwitek, Ake Lernmark, Jack Gorski, Hartmut Weiler
Journal: Blood
Blood (2008) 112 (13): 4905–4914.
https://doi.org/10.1182/blood-2008-03-146555
Published: 2008
Includes: Supplemental data